(NYSE: GSK) Gsk's forecast annual revenue growth rate of 2.91% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 7.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.2%.
Gsk's revenue in 2025 is $41,485,526,315.On average, 3 Wall Street analysts forecast GSK's revenue for 2025 to be $172,371,378,480,000, with the lowest GSK revenue forecast at $168,868,412,160,000, and the highest GSK revenue forecast at $174,785,751,280,000. On average, 4 Wall Street analysts forecast GSK's revenue for 2026 to be $178,737,007,680,000, with the lowest GSK revenue forecast at $174,096,964,160,000, and the highest GSK revenue forecast at $181,916,286,160,000.
In 2027, GSK is forecast to generate $184,779,182,056,000 in revenue, with the lowest revenue forecast at $182,627,312,000,000 and the highest revenue forecast at $187,745,896,800,000.